Gene copy number regulates the production of the human chemokine CCL3-L1

European Journal of Immunology

Volumn 32, Issue 10, 2002, Pages 3016-3026

  Townson, Jane R ^a   Barcellos, Lisa F ^b   Nibbs, Robert J B ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokine; Chemotaxis; Gene expression; Monocyte

Indexed keywords

ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; CAUCASIAN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIPLOIDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENE NUMBER; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYPOTHESIS; INFECTION; INFLAMMATORY DISEASE; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SAMPLE; SUPERNATANT;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHEMOKINES, CC; GENE DOSAGE; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MONOCYTES; POLYMERASE CHAIN REACTION; PROTEIN ISOFORMS; U937 CELLS;

EID: 0036772531     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D     Document Type: Article

References (52)

1. Gerard, C. and Rollins, B., Chemokines and disease. Nat. Immunol. 2001. 2: 108-115.
2. Moser, B. and Loetscher, P., Lymphocyte traffic control by chemokines. Nat. Immunol. 2001. 2: 123-128.
3. Mackay, C., Chemokines: immunology's high impact factors. Nat. Immunol. 2001. 2: 95-101.
4. Rossi, D. and Zlotnik, A., The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000. 18: 217-242.
5. Berger, E. A., Murphy, P. M. and Farber, J. M., Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999. 17: 657-700.
6. Garzino-Demo, A., DeVico, A. L., Conant, K. E. and Gallo, R. C., The role of chemokines in human immunodeficiency virus infection. Immunol. Rev. 2000. 177: 79-87.
7. O'Brien, S. J. and Moore, J. P., The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol. Rev. 2000. 177: 99-111.
8. Barcellos, L. F., Schito, A. M., Rimmler, J. B., Vittinghoff, E., Shih, A., Lincoln, R., Callier, S., Elkins, M. K., Goodkin, D. E., Haines, J. L., Pericak-Vance, M. A., Hauser, S. L. and Oksenberg, J. R., CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 2000. 51: 281-288.
9. Gomez-Reino, J. J., Pablos, J. L., Carreira, P. E., Santiago, B., Serrano, L., Vicario, J. L., Balsa, A., Figueroa, M. and de Juan, M. D., Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum. 1999. 42: 989-992.
10. Hall, I. P., Wheatley, A., Christie, G., McDougall, C., Hubbard, R. and Helms, P. J., Association of CCR5Δ 32 with reduced risk of asthma. Lancet 1999. 354: 1264-1265.
11. Moatti, D., Faure, S., Fumeron, F., Amara, M. el-W., Seknadji, P., McDermott, D. H., Debre, P., Aumont, M. C., Murphy, P. M., de Prost, D. and Combadiere, C., Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 2001. 97: 1925-1928.
12. Cook, D. N., Beck, M. A., Coffman, T. M., Kirby, S. L., Sheridan, J. F., Pragnell, I. B. and Smithies, O., Requirement of MIP-1α for an inflammatory response to viral infection. Science 1995. 269: 1583-1585.
13. Tumpey, T. M., Cheng, H., Cook, D. N., Smithies, O., Oakes, J. E. and Lausch, R. N., Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J. Virol. 1998. 72: 3705-3710.
14. + T cells are a biologically relevant source of macrophage inflammatory protein-1α in vivo. J. Immunol. 1999. 162: 5423-5428.
15. Olszewski, M. A., Huffnagle, G. B., Traynor, T. R., McDonald, R. A., Cook, D. N. and Toews, G. B., Regulatory effects of macrophage inflammatory protein 1α/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect. Immun. 2001. 69: 6256-6263.
16. Serody, J. S., Burkett, S. E., Panoskaltsis-Mortari, A., Ng-Cashin, J., McMahon, E., Matsushima, G. K., Lira, S. A., Cook, D. N. and Blazar, B. R., T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 2000. 96: 2973-2980.
17. McMahon, E. J., Cook, D. N., Suzuki, K. and Matsushima, G. K., Absence of macrophage-inflammatory protein-1α delays central nervous system demyelination in the presence of an intact blood-brain barrier. J. Immunol. 2001. 167: 2964-2971.
18. Cameron, M. J., Arreaza, G. A., Grattan, M., Meagher, C., Sharif, S., Burdick, M. D., Strieter, R. M., Cook, D. N. and Delovitch, T. L., Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J. Immunol. 2000. 165: 1102-1110.
19. Zagury, D., Lachgar, A., Chams, V., Fall, L. S., Bernard, J., Zagury, J. F., Bizzini, B., Gringeri, A., Santagostino, E., Rappaport, J., Feldman, M., O'Brien, S. J., Burny, A. and Gallo, R. C., C-C chemokines, pivotal in protection against HIV type 1 infection. Proc. Natl. Acad. Sci. USA 1998. 95: 3857-3861.
20. Garzino-Demo, A., Moss, R. B., Margolick, J. B., Cleghorn, F., Sill, A., Blattner, W. A., Cocchi, F., Carlo, D. J., DeVico, A. L. and Gallo, R. C., Spontaneous and antigen-induced production of HIV-inhibitory β-chemokines are associated with AIDS-free status. Proc. Natl. Acad. Sci. USA 1999. 96: 11986-11991.
21. + T cells are associated with asymptomatic HIV-1 infection. Proc. Natl. Acad. Sci. USA 2000. 97: 13812-13817.
22. Gallo, R. C., Garzino-Demo, A. and De Vico, A. L., HIV infection and pathogenesis: what about chemokines? J. Clin. Immunol. 1999. 19: 293-299.
23. Gonzalez, E., Dhanda, R., Bamshad, M., Mummidi, S., Geevarghese, R., Catano, G., Anderson, S. A., Walter, E. A., Stephan, K. T., Hammer, M. F., Mangano, A., Sen, L., Clark, R. A., Ahuja, S. S., Dolan, M. J. and Ahuja, S. K., Global survey of genetic variation in CCR5, RANTES, and MIP-1α: impact on the epidemiology of the HIV-1 pandemic. Proc. Natl. Acad. Sci. USA 2001. 98: 5199-5204.
24. Nakao, M., Nomiyama, H. and Shimada, K., Structures of human genes coding for cytokine LD78 and their expression. Mol. Cell. Biol. 1990. 10: 3646-3658.
25. Irving, S. G., Zipfel, P. F., Balke, J., McBride, O. W., Morton, C. C., Burd, P. R., Siebenlist, U. and Kelly, K., Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q. Nucleic Acids Res. 1990. 18: 3261-3270.
26. Nibbs, R. J., Yang, J., Landau, N. R., Mao, J. H. and Graham, G.,J., LD78β, a non-allelic variant of human MIP-1α (LD78α), has enhanced receptor interactions and potent HIV suppressive activity. J. Biol. Chem. 1999. 274: 17478-17483.
27. Menten, P., Struyf, S., Schutyser, E., Wuyts, A., De Clercq, E., Schols, D., Proost, P. and Van Damme, J., The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. J. Clin. Invest. 1999. 104: R1-5.
28. Struyf, S., Menten, P., Lenaerts, J. P., Put, W., D'Haese, A., De Clercq, E., Schols, D., Proost, P. and Van Damme, J., Diverging binding capacities of natural LD78β isoforms of macrophage inflammatory protein-1α to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur. J. Immunol. 2001. 31: 2170-2178.
29. Nibbs, R. J., Kriehuber, E., Ponath, P. D., Parent, D., Qin, S., Campbell, J. D., Henderson, A., Kerjaschki, D., Maurer, D., Graham, G. J. and Rot, A., The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 2001. 158: 867-877.
30. Proost, P., Menten, P., Struyf, S., Schutyser, E., De Meester, I. and Van Damme, J., Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonist. Blood 2000. 96: 1674-1680.
31. De Meester, I., Korom, S., Van Damme, J. and Scharpe, S., CD26, let it cut or cut it down. Immunol. Today 1999. 20: 367-375.
32. Aquaro, S., Menten, P., Struyf, S., Proost, P., Van Damme, J., De Clercq, E. and Schols, D., The LD78β isoform of MIP-1α is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages. J. Virol. 2001. 75: 4402-4406.
33. Nibbs, R. J. B., Wylie, S. M., Pragnell, I. B. and Graham, G. J., Cloning and characterization of a novel murine β chemokine receptor, D6. Comparison to three other macrophage inflammatory protein-1α receptors, CCR-1, CCR-3 and CCR-5. J. Biol. Chem. 1997. 272: 12495-12504.
34. Nomiyama, H., Mera, A., Ohneda, O., Miura, R., Suda, T. and Yoshie, O., Organization of the chemokine genes in the human and mouse major clusters of CC and CXC chemokines: diversification between the two species. Genes Immun. 2001. 2: 110-113.
35. Naruse, K., Ueno, M., Satoh, T., Nomiyama, H., Tei, H., Takeda, M., Ledbetter, D. H., Coillie, E. V., Opdenakker, G., Gunge, N., Sakaki, Y., Iio, M. and Miura, R., A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. Genomics 1996. 34: 236-240.
36. Tasaki, Y., Fukuda, S., Iio, M., Miura, R., Imai, T., Sugano, S., Yoshie, O., Hughes, A. L. and Nomiyama, H., Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1α/LD78α-like genes. Genomics 1999. 55: 353-357.
37. Lindhout, E., Vissers, J. L., Hartgers, F. C., Huijbens, R. J., Scharenborg, N. M., Figdor, C. G. and Adema, G. J., The dendritic cell-specific CC-chemokine DC-CK1 is expressed by germinal center dendritic cells and attracts CD38-negative mantle zone B lymphocytes. J. Immunol. 2001. 166: 3284-3289.
38. Adema, G. J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y., Nooyen, P., McClanahan, T., Bacon, K. B. and Figdor, C. G., A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997. 387: 713-717.
39. Nibbs, R. J. B., Salcedo, T. W., Campbell, J. D. M., Yao, X.-T., Li, Y., Nardelli, B., Olsen, H. S., Morris, T. S., Proudfoot, A. E. I., Patel, V. P. and Graham, G. J., CCR3 antagonism by the β-chemokine MIP4, a property strongly enhanced by an amino-terminal alanine-methionine swap. J. Immunol. 2000. 164: 1488-1497.
40. International Union of Immunological Societies/World Health Organization Subcommittee on chemokine nomenclature, Chemokine/chemokine receptor nomenclature. J. Leukoc. Biol. 2001. 70: 465-466.
41. Yoshida, T., Imai, T., Takagi, S., Nishimura, M., Ishikawa, I., Yaoi, T. and Yoshie, O., Structure and expression of two highly related genes encoding SCM-1/human lymphotactin. FEBS Lett. 1996. 395: 82-88.
42. Nakano, H. and Gunn, M. D., Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J. Immunol. 2001 166: 361-369.
43. Townson, J. R. and Nibbs, R. J. B., Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25. SLC, mCCL21 and MIP-3β/mCCL19: comparison to human CCX-CKR. Eur. J. Immunol. 2002. 32: 1230-1241.
44. Murphy, P. M., Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2001. 2: 116-122.
45. Liu, H., Chao, D., Nakayama, E. E., Taguchi, H., Goto, M., Xin, X., Takamatsu, J. K., Saito, H., Ishikawa, Y., Akaza, T., Juji, T., Takebe, Y., Ohishi, T., Fukutake, K., Maruyama, Y., Yashiki, S., Sonoda, S., Nakamura, T., Nagai, Y., Iwamoto, A. and Shioda, T., Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc. Natl. Acad. Sci. USA 1999. 96: 4581-4585.
46. McDermott, D. H., Beecroft, M. J., Kleeberger, C. A., Al-Sharif, F. M., Ollier, W. E., Zimmerman, P. A., Boatin, B. A., Leitman, S. F., Detels, R., Hajeer, A. H. and Murphy, P. M., Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 2000. 14: 2671-2678.
47. Rowland-Jones, S., Pinheiro, S. and Kaul, R., New insights into host factors in HIV-1 pathogenesis. Cell 2001. 104: 473-476.
48. Townson, J. R., Graham, G. J., Landau, N. R., Rasala, B. and Nibbs, R. J., Aminooxypentane addition to the chemokine macrophage inflammatory protein-1αP increases receptor affinities and HIV inhibition. J. Biol. Chem. 2000. 275: 39254-39261.
49. Sambrook, J. and Russell, D. W. (Eds.) Molecular cloning: a laboratory manual. 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor 2001.
50. Baird, J. W., Nibbs, R. J., Komai-Koma, M., Connolly, J. A., Ottersbach, K., Clark-Lewis, I., Liew, F. Y. and Graham, G. J., ESkine, a novel β-chemokine, is differentially spliced to produce secretable and nuclear targeted isoforms. J. Biol. Chem. 1999. 274: 33496-33503.
51. Goodkin, D. E., Doolittle, T. H., Hauser, S. S., Ransohoff, R. M., Roses, A. D. and Rudick, R. A., Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch. Neurol. 1991. 48: 805-807.
52. The Multiple Sclerosis Genetic Group, Clinical Demographics of multiplex families with multiple sclerosis. Ann. Neurol. 1998. 43: 530-534.